Infectious Diseases

Infectious Diseases

Benito Almirante

Researchers
María José Buzón Gómez, Manuel Crespo Casal, Adrian Curran Fabregas, Vicente Falcó Ferrer, Nuria Fernández Hidalgo, Victor Franco Puntes, Joan Gavaldà Santapau, Jordi Gomez i Prat, Oscar Len Abad, Israel Molina Romero, Raisa Morales Martinez, Inmaculada Ocaña Rivera, Carles Pigrau Serrallach, Diana Pou Ciruelo, Esteve Ribera Pascuet, Ma Dolores Rodríguez Pardo, Isabel Ruiz Camps, Jose Santos Santiago, Nuria Serre Delcor, Antonio Soriano Arandes, Begoña Treviño Maruri

Researchers in training
Mª Luisa Aznar Ruiz de Alegría, Jana Basas Satorras, Maria Cristina Bocanegra Garcia, Joaquin Burgos Cibrian, Johanna Milena Caro Mendivelso, Antoinette Frick , Jordi Navarro Mercadé, Mireia Puig Asensio, Fernando M Salvador Velez, Adrián Sánchez Montalvá

Nursing, Technical, and Administrative Staff
Mercedes Baone Toronjo, Isabel Claveria Guiu, Nuria Coma Auli, Esperanza Esteban Serna, Mª Carmen Ferrer Barberà, Lidia García Losada, Javier Gomis Rodriguez, Roser Navarro Garcia, Hakima Ouaarab Essadek, Mercè Pérez Bernal, Edurne Ruiz Marti, Ariadna Torrella Domingo, Immaculada Verdeguer Almaraz, Francesc Zarzuela Serrat

SUMMARY

During 2014 the Research Group on Infectious Diseases has developed projects related to new therapeutic options for multi-resistant bacterial infections, the epidemiology and therapy of tropical diseases in our country, with the epidemiology and prognosis of serious infections in immunocompromised patients and assessment of new strategies for antiretroviral treatment. Our group has published a great number of articles in indexed journals and has obtained more than 10 projects with competitive funding.

PUBLICATIONS

Total 66.
Impact Factor 325.547
Average I.F. 4.933

  • Abril V, Aguado JM, Aller AI, Almela M, Almirante B, Alonso M, Ayarza R, Bereciartua E, Blanquer J, Buendia B, Camarena JJ, Campelo C, Chavez M, Cuenca-Estrella M, de los Santos I, Delgado-Iribarren A, Diaz-Martin A, Ezpeleta G, Fernandez-Ruiz M, Fortun J, Gadea I, Garcia C, Garcia J, Garnacho-Montero J, Gene A, Gimeno C, Gomez E, Gomez J, Gonzalez F, Gorgolas M, Guinea J, Gurgui M, Hernaez S, Hernandez JL, Horcajada JP, Losa JE, Loza A, Ma Planes A, Maroto FL, Martin P, Martinez-Montauti J, Martin-Mazuelos E, Martin-Mazuelos E, Mensa J, Merino P, Montejo M, Mularoni A, Munoz P, Navarro D, Ortiz C, Padilla B, Pano JR, Peman J, Peman J, Perez B, Puchades F, Puig-Asensio M, Ramos A, Rivas RA, Rodriguez-Bano J, Romero Y, Ruiz M, Ruiz-Camps I, Ryan P, Salavert M, Sanchez I, Sanchez-Reus F, Sanz F, Sierra M, Sorli L, Suarez AI, Urrea M, Valerio M, Zaragoza O, Zaragoza R. Impact of therapeutic strategies on the prognosis of candidemia in the ICU.Crit Care Med. 2014 Jun;42(6):1423-32. doi: 10.1097/CCM.0000000000000221. IF: 6,147
  • Almirante B, Beloin C, Chauhan A, Fernandez-Hidalgo N, Ghigo JM, Lebeaux D, Lee S. Management of infections related to totally implantable venous-access ports: challenges and perspectives.Lancet Infect Dis. 2014 Feb;14(2):146-59. doi: 10.1016/S1473-3099(13)70266-4. IF: 19,446
  • Cuenca-Estrella M, Fortun J, Gavalda J, Grossi P, Lortholary O, Meije Y, Munoz P, Roilides E, Saliba F. Invasive fungal infections in solid organ transplant recipients.Clin Microbiol Infect. 2014 Sep;20 Suppl 7:27-48. doi: 10.1111/1469-0691.12660. IF: 5,197
  • Blanco-Grau A, Cabezos J, Gomez i Prat J, Molina I, Pahissa A, Pou D, Roure S, Salvador F, Sanchez-Montalva A, Serre N, Sulleiro E, Trevino B, Valerio L, Vidal X. Randomized trial of posaconazole and benznidazole for chronic Chagas’ disease.N Engl J Med. 2014 May 15;370(20):1899-908. doi: 10.1056/NEJMoa1313122. IF: 54,420
  • Crespo M, Crespo M, Curran A, Curran A, Domingo P, Domingo P, Fernandez I, Fernandez I, Ibarguren M, Imaz A, Imaz A, Iribarren JA, Iribarren JA, Knobel H, Knobel H, Martinez E, Martinez E, Monteiro P, Monteiro P, Navarro J, Penaranda M, Penaranda M, Podzamczer D, Podzamczer D, Ribera E, Riera M, Villar J, Villar J. Effectiveness of ritonavir-boosted protease inhibitor monotherapy in the clinical setting: same results as in clinical trials? The PIMOCS Study Group.J Antimicrob Chemother. 2014 May;69(5):1390-6. doi: 10.1093/jac/dkt517. IF: 5,439

 

View all the publications

MAIN RESEARCH PROJECTS

  • PI: Molina Romero, Israel
    Benznidazol and Triazol REsearch group for Nanomedicine and Innovation on Chagas disease (BERENICE)Grant Agreement nº 305937
    Funding Agency: European Commission
    Reference: BERENICE_FP7HEALTH2012
    Funding: 2.998.217,00 €
    From: 2012 to: 2017
  • PI: Pahissa Berga, Albert
    Incremento de la liberación de combinaciones de antimicrobianos nebulizados mediante nanotecnología en el modelo murino de infección respiratoria por P.aeruginosa multiresistente. Proyecto Nanoneb-Par
    Funding Agency: Fondo de Investigación Sanitaria
    Reference: PI13/02551
    Funding: 181.681,50 €
    From: 2014 to: 2016
  • PI: Ribera Pascuet, Esteve
    Determinación de concentraciones de antirretrovirales en cabello en poblaciones especiales de pacientes infectados por el virus de la inmunodeficiencia humana
    Funding Agency: Fondo de Investigación Sanitaria
    Reference: PI12/01840
    Funding: 93.775,00 €
    From: 2013 to: 2015
  • PI: Almirante Gragera, Benito
    Impacto del genotipo y el fenotipo de Staphylococcus aureus en las características clínicas y la evolución de la endocartitis infecciosa
    Funding Agency: Fondo de Investigación Sanitaria
    Reference: PI12/01719
    Funding: 54.450,00 €
    From: 2013 to: 2015
  • PI: Franco Puntes, Victor
    Project acronym: GUIDEnanoGrant agreement no: 604387
    Funding Agency: Reference: GUIDENANO_FP7NMP2013
    Funding: 391.512,80 €
    From: 2013 to: 2017

 

View all the research projects